Cite

HARVARD Citation

    Arai, T. et al. (2022). Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study. JGH open. 6 (7), pp. 503-511. [Online]. 
  
Back to record